Direkt zum Inhalt
Merck

Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.

Antimicrobial agents and chemotherapy (2014-09-04)
Maria V Papadopoulou, William D Bloomer, Howard S Rosenzweig, Alexander Arena, Francisco Arrieta, Joseph C J Rebolledo, Diane K Smith
ZUSAMMENFASSUNG

Twenty-three 3-nitrotriazole-based and 2-nitroimidazole-based amides and sulfonamides were screened for antitubercular (anti-TB) activity in aerobic Mycobacterium tuberculosis H37Rv by using the BacTiter-Glo (BTG) microbial cell viability assay. In general, 3-nitrotriazole-based sulfonamides demonstrated anti-TB activity, whereas 3-nitrotriazole-based amides and 2-nitroimidazole-based amides and sulfonamides were inactive. Three 3-nitrotriazole-based sulfonamides (compounds 4, 2, and 7) demonstrated 50% inhibitory concentration (IC50), IC90, and MIC values of 0.38, 0.43, and 1.56 μM (compound 4), 0.57, 0.98, and 3.13 μM (compound 2), and 0.79, 0.87, and 3.13 μM (compound 7), respectively. For 3-nitrotriazole-based sulfonamides, anti-TB activity increased with lipophilicity, whereas the one-electron reduction potential (E1/2) did not play a role. 2-Nitroimidazole-based analogs, which were inactive in the BTG assay, were significantly more active in the low-oxygen assay and more active than the 3-nitrotriazoles. All active nitrotriazoles in the BTG assay were similarly active or more potent (lower MIC values) against resistant strains, with the exception of compounds 2, 3, 4, and 8, which demonstrated greater MIC values against isoniazid-resistant strains. Five 3-nitrotriazole-based sulfonamides demonstrated activity in infected murine J774 macrophages, causing log reductions similar to those seen with rifampin. However, some compounds caused toxicity in uninfected macrophages. In conclusion, the classes of 3-nitrotriazole-based amides and sulfonamides merit further investigation as potential antitubercular agents.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycerin, ACS reagent, ≥99.5%
Sigma-Aldrich
Glycerin, for molecular biology, ≥99.0%
Sigma-Aldrich
Glycerin, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
D-(+)-Glukose, ≥99.5% (GC)
Sigma-Aldrich
D-(+)-Glukose, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.5%
Sigma-Aldrich
Dextrose, 97.5-102.0% anhydrous basis, meets EP, BP, JP, USP testing specifications
Sigma-Aldrich
D-(+)-Glukose, ≥99.5% (GC), BioXtra
Sigma-Aldrich
Glycerin -Lösung, 83.5-89.5% (T)
Sigma-Aldrich
Glycerin, ≥99.5%
Sigma-Aldrich
Glycerin, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glycerin, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
USP
Dextrose, United States Pharmacopeia (USP) Reference Standard
USP
Glycerin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-(+)-Glukose, ACS reagent
Sigma-Aldrich
Glycerin, FCC, FG
Sigma-Aldrich
D-(+)-Glukose, BioUltra, anhydrous, ≥99.5% (sum of enantiomers, HPLC)
Supelco
D-(+)-Glukose, analytical standard
Supelco
Dextrose, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Glycerin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycerin, BioXtra, ≥99% (GC)
Sigma-Aldrich
D-(+)-Glukose, suitable for mouse embryo cell culture, ≥99.5% (GC)
Sigma-Aldrich
Glycerin, meets USP testing specifications
Sigma-Aldrich
Amikacin -disulfat (Salz), potency: 674-786 μg per mg (as amikacin base)
Sigma-Aldrich
D-(+)-Glukose, Hybri-Max, powder, BioReagent, suitable for hybridoma
Supelco
Glycerin, analytical standard
Sigma-Aldrich
Glycerin, tested according to Ph. Eur., anhydrous
Sigma-Aldrich
D-(+)-Glukose, 99.9 atom % 16O, 99.9 atom % 12C
USP
Amikacinsulfat, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-(+)-Glukose, tested according to Ph. Eur.
Amikacin -sulfat, European Pharmacopoeia (EP) Reference Standard